Emergent TAVI for severe aortic valve narrowing
Part of Heart & circulation clinical trials.
This trial studies a faster, emergency version of a valve replacement done through the blood vessels (TAVI) for people with severe aortic valve narrowing. It aims to check whether this approach is safe and works when people are in urgent, hard-to-stabilize situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with severe aortic valve stenosis on an echocardiogram
- Your situation is urgent or an emergency (for example, cardiac arrest/needed chest compressions, or worsening heart condition not responding to other treatments)
- You (or your legal representative) can agree to the study and sign consent, and you can return for follow-up visits
- The valve replacement route through your heart and main artery must be technically possible based on imaging
- You must not have certain heart/medical issues that block the procedure or raise risk, like blood clot in the heart, major outflow blockage, or active serious infection
- You must be able to take blood thinners and anti-platelet medicines, and you must not have a nickel-titanium allergy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial studies how safe and effective the NAVITOR valve is for treating narrowed aortic valves placed through a catheter (no open-heart surgery). It may be an option if you’re at intermediate-to-low surgical risk and meet heart ultrasound/CT measurements.
This trial tests a new heart valve replacement (TAVR) system in people with severe, symptomatic aortic stenosis. If you qualify, it may offer a less invasive option compared with open-heart valve surgery, while also helping researchers understand safety and early effectiveness.
This study compares regular monitoring (“clinical surveillance”) versus replacing the aortic valve using a minimally invasive procedure called TAVR for people with moderate aortic stenosis. It aims to see which approach better reduces symptoms or heart damage over time.
This study tests whether a procedure called TAVI (a valve replacement done through a tube in the leg) can help people with severe aortic stenosis who are in cardiogenic shock, a dangerous condition where the heart can't pump enough blood. The goal is to see if urgent valve replacement improves survival.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.